Transduction of the herpes simplex virus thymidine kinase (HSV-tk) into vascular endothelial cells us ing a replication-defective adenoviral vector (Ad.CMV-tk) to confer sensitivity to ganciclovir (GCV) was investigated. The cytotoxic sensitivity of bovine aortic endothelial cells (BAEC) to GCV following Ad.CMV-tk transduction at multiplicity of infection of 100 was ten-fold that of 9L glioma cells in vitro. Deoxyribonucleic acid fragmentation was detected in these BAEC. A co-culture experiment using BAEC transduced with Ad.CMV-tk (BAEC-tk) and 9L cells expressing &beta;-galactosidase (9L-Lac Z) showed about 70% tumoricidal effect under the conditions of one BAEC-tk cell in 10 9L-Lac Z cells. Tumor-bearing Fisher 344 rats, an experimental brain tumor model, received Ad.CMV-tk intratumoral ly at 7 days after tumor implantation, and were subsequently treated with intraperitoneal GCV (100 mg/kg). Histological examination found the vascular endothelial cells adjacent to 9L glioma tissue re vealed apoptosis. These results suggest that vascular endothelial cells are an attractive target for adenoviral-mediated HSV-tk gene therapy.
Introduction
Adenoviral-mediated gene therapy based on the transfer of a suicide gene into tumor cells has been effective for curing brain tumors in animal models.6,21J Such viral-mediated transfer of the herpes simplex virus thymidine kinase (HSV-tk) gene has been used to confer cytotoxic sensitivity to nucleo side analogues, such as ganciclovir (GCV), in a varie ty of tumor cells in vitro and in vivo. 6, 10, 21, 22, 25, 27 ) HSV tk gene transduction followed by GCV exposure causes the killing of glioma cells directly. However, the target for cytotoxic therapy using suicide gene transduction includes both the tumor cells and tumor-associated vascular endothelial cells, since vascular endothelial cells are also infected even if the viral vehicle is injected intratumorally.4) Proliferating tumor-associated vascular endotheli al cells are a favorable target for viral-mediated gene therapy for three reasons. First, vascular endothelial The present study investigated the adenoviral mediated gene transduction efficiency and sensitivi ty to GCV in both bovine aortic endothelial cells (BAEC) and 9L rat gliosarcoma cells to examine whether vascular endothelial cells transduced with adenoviral vector expressing suicide gene are sensi tized and whether vascular endothelial cell-glioma cell contact leads to an innocent bystander effect similar to that seen in glioma cell-glioma cell contact by a co-culture experiment with BAEC and 9L. An animal model of glioma, induced 9L glioma in the rat, was used to assess if adenoviral vectors transfer genes to cerebral microcapillary endothelial cells in vivo, and the killing mechanism of the vascular en dothelial cells was assessed to detect apoptosis or programmed cell death as determined by deox yribonucleic acid (DNA) fragmentation analysis in vitro and in situ apoptosis detection in vivo. Cell culture and preparation of recombinant adenovirus: 9L rat gliosarcoma cells were main tained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS). BAEC were maintained in DMEM containing 10% FBS, 100,ug/ml heparin, and 30,ug/ml endothelial cell growth supplement (Collaborative Biomedical Products, Bedford, Mass., U.S.A.).
The recombinant adenoviruses Ad.CMV-Lac Z and Ad.CMV-tk derived from adenovirus type 5 were prepared by homologous recombination in human embryonic kidney cell line (HEK) 293 as previously described.",") In brief, Ad.CMV-tk was prepared by cotransfection of pJM17 and a shuttle plasmid containing HSV-tk gene driven by the cytomegalovirus (CMV) promoter/enhancer . The vi rus stocks were purified by two cesium chloride ultracentrifugations, dialyzed against 10% glycerol , 10 mM Tris (pH 7.4), and 1 MM MgC12i and stored at -80° C . Viral titers were determined by the plaque forming unit (pfu) Evaluation of in vitro bystander effect: The viabil ity of wild type BAEC treated with GCV was meas ured in the presence of BAEC transduced with Ad.CMV-tk (BAEC-tk) at the MOI of 100. Briefly, wild type BAEC were mixed with BAEC-tk cells at different ratios and then plated in a 6-well plate at 1 x 105 cells/well. Cells were treated with 10 uM of GCV for 72 hours. The cytotoxicity assay was per formed as described above.
In order to test whether this effect was also ob served in glioma-endothelial cell contact, a co-cul ture experiment was performed with BAEC-tk and 9L glioma cells with stably transduced 8-galactosi dase gene using CREBAG2 retroviral producer cells (9L-Lac Z). 1 X 105 of 9L-Lac Z cells and different amounts of BAEC-tk cells (1 x 104, 2 X 104, 5 x 104, 8 x 104, 1 x 105) were plated together and then ex posed to 10,uM of GCV. Seventy-two hours after treatment, the cells were stained with X-gal, or har vested and subjected to the 8-galactosidase assay as described above. The relative activity in each condi tion was calculated as a percentage of the activity of 9L-Lac Z without BAEC-tk.
Evaluation
of DNA fragmentation: BAEC (5 X 106 cells) following adenoviral infection at MOI of 0, 100, and 500 were exposed to GCV (10,uM) for 12 hours then harvested, washed, and incubated in 100,ul of 50 mM Tris (pH 8.0), 10 mM ethylenediaminetetra-acetic acid (EDTA), 0.5% sodi um dodecyl sulfate, and 0.5 yg/ml proteinase K for 3 hours at 50'C. Fifty microliters of 0.5 mg/ml ribonuclease A was added and incubation continued for an additional 1 hour. The digested samples were incubated with 100 ,ul of 10 mM EDTA (pH 8.0) con taining 2% (w/v) low-melting point agarose, 0.25% bromophenol blue, and 40% sucrose at 70° C. The DNA was separated in gels containing 2% agarose/ TAE buffer (40 mM Tris-acetate and 1 mM EDTA [pH 8.0]) and visualized by ultraviolet illumination after ethidium bromide staining.
II.
In vivo adenoviral-mediated cytotoxic sensiti zation Adenoviral-mediated cytotoxic sensitization model: Adult male Fisher 344 rats (200-250 g) were purchased from Charles River Laboratories (Wilmington, Mass., U.S.A.). All animal studies confirmed to the guidelines of the Animal Care and Use Committee of Dana-Farber Cancer Institute.
Rats were anesthetized by intraperitoneal injec tion of nembutal. Twenty thousand 9L gliosarcoma cells suspended in 10 pl Hank's balanced salt solu tion were injected over 30 seconds into the rat cau date nucleus to a depth of 4.5 mm using a small animal stereotactic frame (Kopf) and a 25 gauge Hamilton syringe. The needle was left in place for 1 minute and then withdrawn slowly. Seven days after tumor implantation, the rats were treated with 6 pl of Ad.CMV-Lac Z (1.2 x 109 pfu) or Ad.CMV-tk (1.2 x 109 pfu) by injection into the established 9L brain tumors using the same stereotactic coordinates. GCV treatment began 2 days after viral inoculation at a dose of 100 mg/kg body weight by in traperitoneal injection. The rat brains were harvest ed the next day for further histological analysis.
Evaluation of /3-galactosidase gene transduction: The brains were removed and cryoprotected in 20% sucrose in PBS and frozen in ornithine carbamoyl transferase.
Coronal sections (6,um) were taken from the tumor implantation site and immersed in X-gal staining solution (5 mM K4Fe(CN)6, 5 mM K3Fe(CN)6i 1 MM MgCl2, and 1 mg/ml X-gal in PBS) as described. Finally the sections were counter stained with nuclear fast red. peroxidase in methanol. Non-specific binding was blocked with 10% normal horse serum and 1% bo vine serum albumin (BSA) for 30 minutes. After a brief rinse, the sections were immunoreacted with a proliferating cell nuclear antigen (PCNA) monoclonal antibody diluted 1:500 in PBS with 1% BSA and 0.1% Tween 20 at room temperature for 30 minutes followed by biotinylated anti-mouse im munoglobulin G for 30 minutes. The sections were then treated with avidin-biotin-horseradish peroxi dase complex for 1 hour and 3-3' diaminobenzidine was applied as a chromogen. Sections were counter stained with 1% methylene green. 
Results
I. In vitro adenoviral-mediated cytotoxic sensiti zation Evaluation of transduction efficiency in BAEC and 9L cells showed that using the same MOI of Ad.CMV-Lac Z infection, /3-galactosidase activity in BAEC was higher than that in 9L (Fig. 1) .
Evaluation of the cytotoxic sensitization by trans duction of Ad.CMV-tk showed that both 9L cells and BAEC were killed by GCV treatment and the effect was dependent on GCV dose and MOI. The median lethal dose for GCV cytotoxicity to BAEC at a MOI of 100 was 0.08,uM, which showed ten-fold sensitivi ty compared with 9L cells (Fig. 2) .
Evaluation of the bystander effect showed that wild type and Ad.CMV-tk-transduced BAEC mixed at different ratios and then exposed to 10,uM of GCV had lower cell viability than the cells treated with GCV separately and then mixed (Fig. 3 upper) . Wild type BAEC cells were only 13.7 ± 3.4% viable even if as few as 10% of the mixed cell population were HSV-tk positive. Co-culture of 9L-Lac Z cells with BAEC-tk showed the same effect, as demonstrated by /1-galactosidase activity (Fig. 3 lower) , and posi tive X-gal staining (Fig. 4) . This decrease in /3-galac tosidase activity was dependent on the proportion of BAEC-tk cells in the co-culture (Fig. 3 lower) .
Evaluation of DNA fragmentation showed that BAEC transduced with HSV-tk at a MOI of 500 un derwent internucleosomal DNA fragmentation fol lowing exposure to 10 ,uM GCV (Fig. 5) . Relative /3 galactosidase activity was compared to that of 9L cells infected with Ad.CMV-Lac Z at MOI of 10. II. In vivo adenoviral-mediated cytotoxic sensiti zation Evaluation of gene transduction by the Ad.CMV Lac Z using X-gal staining showed blue coloration of the vasculature, indicative of B-galactosidase activi ty in the vascular endothelial cells (Fig. 6A) . Evalua tion of proliferation potential using PCNA immuno histochemical staining demonstrated that vascular endothelial cells as well as tumor cells were strongly positive for PCNA (Fig. 6B) . Evaluation in in situ cell apoptosis showed that vasculatures associated with the induced 9L gliosarcoma contained apoptotic cells as determined by direct immunoperoxidase de tection of the digoxigenin-labeled internucleosome DNA fragment (Fig. 6C) . In contrast, no cell apopto sis was detected in a control group (data not shown). upper: Wild type (WT) bo vine aortic endothelial cells (BAEC) and BAEC transduced with herpes simplex vi rus thymidine kinase gene (BAEC-tk) at multiplicity of infection (MOI) of 100 were mixed at the indicated ratios and then ex posed to 10,uM of GCV (shaded column). WT BAEC and BAEC-tk cells (at MOI of 100) were also treated separately with 10 ,uM of GCV and then mixed at the indicated ratios (open column). lower: 9L glioma cells stably transduced with CREBAG2, a retroviral vector containing /1-galactosi dase gene (9L-Lac Z), and BAEC-tk (at MOI of 100) were mixed at the indicated ratios, and then exposed to 10 ,uM of GCV (shaded column). 9L-Lac Z and BAEC-tk (at MOI of 100) were also treated separately with 10 aM of GCV, and then mixed at the indicated ratios (open column). /1-Galactosidase ac tivity was determined by the absorption at 420 nm and relative activity was deter mined as a percentage of the activity of 9L Lac Z alone. The results are expressed as the mean of three independent experiments; bars, SD. Metabolic cooperation, mediated by gap junctions, is a major contributor to this phenomenon.') This study also found that non-transduced glioma cells which are mixed with HSV-tk-transduced vascular endothelial cells were sensitized to GCV treatment. These in vitro results suggest that vascular endotheli al cells are a favorable target for HSV-tk-GCV ther apy.
Anti-tumor therapy using viral vectors expressing HSV-tk delivered by intratumoral injection is con sidered to be more efficient compared to adminis tration by intracarotid injection as a specific anti endothelial therapy. GCV is always administered sys temically following intratumoral gene transduction, so the vascular endothelial cells are the first to be ex posed to GCV.
The in vivo experiment showed that vascular en dothelial cells within tumor tissue are a good target for cell cycle-dependent HSV-tk gene therapy, be cause of their growth potential shown by the present and previous immunohistochemical analyses with bromodeoxyuridine,20) PCNA,29) or Ki-67.30) Tumor associated endothelial cells in the experimental glio ma model also demonstrated apoptosis following Ad.CMV-tk and GCV treatment, and the X-gal stain ing study showed that infection by adenoviral vector had occurred. The degree of vascularity of gliomas and the proliferation activity of vascular endothelial cells are correlated with the histological grade of malignancy. 5,16, 29) These results suggest that tumor-as sociated vascular endothelial cells infected with Ad.CMV-tk were sensitized to GCV due to the high proportion of cells in the G1-S phase and the high gene transduction efficiency achieved by adenoviral vectors.
Extensive microvasculatures are observed within or adjacent to malignant gliomas, so growth is con sidered to be dependent on angiogenesis. Collapse of the vascular component cells, especially the vas cular endothelial cells, may be a feasible way to in terrupt the oxygen and nutrient delivery to tumor cells, and prevent angiogenesis surrounding the tumor tissue.
To assess the possibility of this viral vector-mediat ed anti-angiogenesis strategy, a novel targeted anti endothelial gene therapy model is presently being de veloped.") 
Commentary
This paper takes the strategy of utilizing the reaction between thymidine kinase and ganciclovir which has been used to provide direct tumor cell damage in ex perimental situations and also clinically. The focus of previous experiments has been the tumor cells them selves, and this paper studies the effect o f this gene therapy strategy on the blood vessels associated with tumors. It has been known for some time that tumor blood vessels are different from normal brain blood vessels, and it has been hoped that these differences could provide the basis for differential therapy that might be capable o f destroying the tumor as a whole. This paper suggests that ganciclovir can produce apoptosis in vascular endothelial cells associated with the 9L glioma after transduction of the cells with adenovirus mediated thymidine kinase. It is encourag ing to see this work which may in fact provide a new avenue of destruction by attacking the vascular supp ly of tumors in addition to the direct cytotoxic effects and the "bystander" effects previously seen with this form of gene therapy. Dr. T. Tanaka has reported the successful transduc tion o f the herpes simplex virus thymidine kinase (HSV-tk) gene using a replication-defective adenoviral vector into vascular endothelial cells. In this study the author clearly showed that the cytotoxic sensitivity of the tumor-associated endothelial cells to ganciclovir was markedly augmented following the HSV-tk trans duction. One of the key issue regarding gene therapy using viral vectors is to restrict the gene expression to target cells. Therefore, certain prom oter/enhancer sys tem specific to endothelial cells should be devised. An giogenesis or neovascularization are generally consi dered to be closely related to endothelial cell prolifera tion that is essential for malignant tumor growth, so the present study of HSV-tk gene transduction is ex pected to contribute to the growth control of malig nant brain tumors in terms of anti-angiogenesis ther apy in the future. Department o f Neurosurgery Nagoya University School of Medicine Nagoya, Japan
